I certainly agree with all that. I do want to apprise you of the fact that, if you're not already aware, there's already a consultation process going on. Certainly CVMA is responding to that, and I'd be glad to forward our comments to the committee for that purpose.
In addition to that, it's what qualifies and doesn't qualify, which is another key factor here. Pure research is one thing, but that doesn't really get us an advantage in the marketplace. We have to take that research and develop it through the various stages to help to meet the commercialization. All along that pathway, I would suggest there are opportunities where the SR and ED credit should not only apply, but it should provide some real benefit. That includes new technologies, new manufacturing processes on the shop floor. That's something that, thus far, does not qualify, but it's certainly something that perhaps takes us to the next level in terms of innovation and competitiveness from a manufacturing standpoint. So that's one other consideration that I would offer here.